DREAMHUG Medical

September 2026

1. 1. The 1-Month tirzepatide price line contains an internal inconsistency in the site's own text: the heading reads '1 Month - $238 (Save $161)' and the total is shown as '$238 total', but the per-month figure printed directly under it is '$39.66/month' — six times lower than the $238 total for the same 1-month plan; this looks like a copy/template bug (the $39.66 may be a stray weekly-rate or leftover value), so both figures are quoted verbatim and flagged rather than corrected. All prices on both product pages are shown as struck-through 'regular' prices next to a '· Today only' discounted price, i.e. every visible price is presented as a limited-time deal rather than a stable list price. Neither product page nor the homepage states an injection form (pen vs. vial) or a tablet/sublingual form for the oral product, or a dose/mg amount for either drug, so form is recorded as not-disclosed throughout. The company advertises pay-as-you-go with no subscription, consistent with its refund policy. Whether the medical evaluation is a live video/phone call or an asynchronous form review was never stated plainly enough to classify, so prescriber is not-found rather than guessed.